EP-1668: The influence of age on survival in elderly patients with resected PC undergoing adjuvant therapy
Bildiriler > Özet Bildiri
Yazarlar: P. Trecca, M. Fiore, B. Floreno, C. Rinaldi, R. Coppola, L.E. Trodella, L. Trodella, R.M. D'Angelillo, S. Ramella
Radiotherapy and Oncology, , , Uluslararası, Özet Bildiri, Wos, cilt 127, ss S896-S896
DOI: 10.1016/s0167-8140(18)31977-7
Özet
S896ESTRO 37The median OS was 34,5 months (95% CI: 29,5-39,5 months) for the entire group; 36,1 (95% CI: 28.9-43,2 months) and 30,8 (95% CI: 24,9-36,6 months) in postoperative and radical setting.In subgroup of patients treated with RT alone, CRT or bioRT the median OS was 34,1 months (95% CI: 28,1-40,1 months), 34,8 (95% CI: 26,1-43,5 months) and 23,8 (95% CI: 16,9-30,7 months) respectively. ConclusionTreatment with radical or postoperative intent in elderly patients with HNSCC should be considered for its acceptable acute toxicity profile and good early results.